Block listing Interim Review
Scorpion Offshore Ltd.
n/a
07:46 20/03/24
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 January 2020
Name of applicant: | Marston's PLC | |||
Name of scheme: | Marston's PLC Save As You Earn Share Option Scheme | |||
Period of return: | From: | 10 July 2019 | To: | 9 January 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 294,714 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 294,714 | |||
Name of contact: | Anne-Marie Brennan |
Telephone number of contact: | 01902 329163 |
BLOCK LISTING SIX MONTHLY RETURN
Information provided on this form must be typed or printed electronically and provided to an ris.
Date: 10 January 2020
Name of applicant: | Marston's PLC | |||
Name of scheme: | Marston's PLC Executive Share Option Scheme | |||
Period of return: | From: | 10 July 2019 | To: | 9 January 2020 |
Balance of unallotted securities under scheme(s) from previous return: | 416,123 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | 0 | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 0 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 416,123 | |||
Name of contact: | Anne-Marie Brennan |
Telephone number of contact: | 01902 329163 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.